hematology

AstraZeneca Showcases Hematology Advancements and Calquence’s Long-Term Efficacy at ASH Annual Meeting

(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting…

5 months ago

Investor AB to accept Agnafit Bidco’s public offer for the shares in Swedish Orphan Biovitrum AB

(PRESS RELEASE) STOCKHOLM, 2-Sep-2021 — /EuropaWire/ — Investor AB (STO: INVE-B), a Swedish investment and holding company founded in 1916,…

3 years ago

University of Zurich researchers announce novel immunotherapy against leukaemia

The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University…

4 years ago

AstraZeneca, Acerta Pharma, MedImmune to present at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego

27 scientific presentations, including long-term data from Calquence in mantle cell lymphoma and updated early-phase trial results in chronic lymphocytic…

5 years ago

Novartis announced patients with myelofibrosis initially randomized to treatment with Jakavi® (ruxolitinib) lived longer

In two Phase III studies, Jakavi ® reduced the risk of death and maintained spleen reductions at three years compared to conventional…

10 years ago